| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |